Literature DB >> 26260935

Psychometric properties of the Somatic Complaints Scale in Spanish children and adults.

Ana Belén Górriz Plumed1, Vicente Javier Prado-Gascó, Lidón Villanueva Badenes, Remedios González Barrón.   

Abstract

BACKGROUND: The aim of this study was to analyse the psychometric properties of the Somatic Complaints List (SCL) in Spanish child and adult populations. This instrument assesses the frequency with which people experience and feel pain such as stomach ache and headache, among others. It has been validated in different countries and languages (Dutch, English, and Persian), showing adequate psychometric properties. Nevertheless, it has never been validated in a Spanish context.
METHOD: For the adaptation and validation, we used two different samples: 1423 children, age ranging from 8 to 12 years old, selected from 12 primary and secondary schools at 7 locations in the Valencian Community, Spain (age = 9.11 years, SD = 1.27; 52.4% female); and 940 adults, age ranging from 18 to 56 years old (age = 32.3 years, SD = 11.62; 64% female).
RESULTS: The Spanish adaptation of the SLC showed adequate levels of reliability and validity.
CONCLUSIONS: The empirical evidence seems sufficient to justify using this diagnostic tool with Spanish children and adults.

Entities:  

Mesh:

Year:  2015        PMID: 26260935     DOI: 10.7334/psicothema2015.8

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  2 in total

1.  Attachment Styles and Well-Being in Adolescents: How Does Emotional Development Affect This Relationship?

Authors:  Estefanía Mónaco; Konstanze Schoeps; Inmaculada Montoya-Castilla
Journal:  Int J Environ Res Public Health       Date:  2019-07-17       Impact factor: 3.390

2.  Serious game to promote socioemotional learning and mental health (emoTIC): a study protocol for randomised controlled trial.

Authors:  Usue De la Barrera; Silvia Postigo-Zegarra; Estefanía Mónaco; José-Antonio Gil-Gómez; Inmaculada Montoya-Castilla
Journal:  BMJ Open       Date:  2021-12-31       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.